Abstract
There is increasing interest in point-of-care diagnostic testing in hospitals and within homes. Advances in engineering and innovation in diagnostic technologies are enabling miniaturized devices (e.g., lab-on-a-chip) at the micro or nanoscale and these devices may eventually provide most if not all of the current range of central laboratory clinical tests at the point-of-care. Specific benefits for miniaturized devices include integration of all steps in a clinical test in single device), replicate analysis for enhanced reliability, portability, low cost, implantability (e.g., in vivo devices), and simplified operation. However, often the true potential of these new technologies cannot be readily assessed because there is inadequate validation with real samples in a clinically relevant environment. It is important to know how common interfering substances (e.g., bilirubin, lipids, hemoglobin, drugs) present in some biological samples may affect a detection technology. Even if a technology can successfully negotiate these hurdles, it must be formatted or packaged to meet the essential requirements of point-of-care testing. This chapter explores the scope of micro and nanotechnologies in the context of point-of-care testing and discusses issues relevant to their implementation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Price, C.P., St. John, A., Hicks, J.M. (eds.): Point of Care Testing, 2nd edn. AACC Press, Washington, DC (2004)
Van den Berghe, G., Wilmer, A., Hermans, G., et al.: Intensive insulin therapy in the medical ICU. NEJM 354, 449–461 (2006)
Noffsinger, R., Chin, S.: Improving the delivery of care and reducing healthcare costs with the digitization of information. J. Healthcare Informat. Manag. 14, 23–30 (2000)
Paxton, A.: Nearing high tide on low blood sugars. CAP Today (March 2006)
Jahn, U.R., Van Aken, H.: Near-patient testing—point-of-care or point of costs and convenience? Br. J. Anaesth. 90, 425–427 (2003)
Kricka, L.J., Park, J.Y.: Prospects for nano- and microtechnologies in clinical point-of-care testing Lab Chip, p. 547 (2007)
Jacobs, E., Hinson, K.A., Tolnai, J., et al.: Implementation, management and continuous quality improvement of point-of-care testing in academic health care setting. Clin. Chim. Acta 307, 49–59 (2001)
Farmer, A.J., Gibson, O.J., Dudley, C., et al.: A randomized controlled trial of the effect of real-time telemedicine support on glycemic control in young adults with Type 1 diabetes (ISRCTN 46889446). Diabetes Care 28, 2697–2702 (2005)
Cheng, J., Kricka, L.J. (eds.): Biochip Technology. Harwood, Philadelphia (2001)
Kricka, L.J., Wilding, P., et al.: Microchip PCR. Anal. Bioanal. Chem. 377, 820–825 (2003)
Kricka, L.J., Wild, D.: Lab-on-a-chip, micro- and nanoscale immunoassay systems. In: Wild, D. (ed.) The Immunoassay Handbook, 3rd edn., pp. 294–309. Elsevier, Amsterdam (2005)
Fortina, P., Kricka, L.J., Park, J.Y., et al.: Beyond microtechnology-nanotechnology in molecular diagnosis. In: Liu, R., Lee, A.P. (eds.) Integrated Biochips for DNA Analysis Landes Bioscience, Austin, TX, pp. 186–197 (2007)
Van Merkerk, R.O., van den Berg, A.: More than technology alone. Lab Chip. 6, 838–839 (2006)
Bennett, J., Cervantes, C., Pacheco, S.: Point-of-care testing: inspection preparedness. Perfusion 15, 137–142 (2000)
Anderson, M.: POCT regulatory compliance: What is it and how does it impact you? Crit. Care Nurs. Quart. 24, 1–6 (2001)
www.cap.org/apps/docs/laboratory_accreditation/checklists/point_of_care_testing_october2005.pdf
McDowell, J.: FDA begins regulating multivariate assays. Clin. Lab News 32, 1–4 (2006)
Medical devices; general hospital and personal use devices; classification of implantable radiofrequency transponder system for patient identification and health information. Final rule. Fed Register 69, 71702–71704 (2004)
Halvorson, M., Carpenter, S., Kaiserman, K., et al.: A pilot trial in pediatrics with the sensor-augmented pump: Combining real-time continuous glucose monitoring with the insulin pump. J. Pediatr. 150, 103–105 (2007)
Ng, S., Po, C., Dagang, G., et al.: MEMSWear – Biomonitoring – Incorporating sensors into smart shirt for wireless sentinel medical detection and alarm. In: J. Phys. Conference Series, vol. 34, pp. 1068–1072 (2006)
Gyselinckx, B., Van Hoof, C., Ryckaert, J., et al.: Human++: Autonomous wireless sensors for body area networks. In: Proceedings of the Custom Integrated Circuits Conference, Proceedings of the IEEE 2005 Custom Integrated Circuits Conference, pp. 12–18 (2005)
Haberzettl, C.A.: Nanomedicine: destination or journey? Nanotechnol 13, R9–R13 (2002)
Bansal, R.: Stranger than fiction? IEEE Microwave magazine 8, 26–28 (2007)
Fortina, P., Kricka, L.J., Surrey, S., et al.: Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol. 23, 168–173 (2005)
Kricka, L.J.: The hitchhikers guide to analytical microchips. AACC Press, Washington (2002)
Kricka, L.J., Park, J.Y., Li, S.F.Y., et al.: Miniaturized detection technology in molecular diagnostics. Exp. Rev. Mol. Diagn. 5, 549–558 (2005)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Park, J.Y., Kricka, L.J. (2009). Role of Nano- and Microtechnologies in Clinical Point-of-Care Testing. In: Yogesan, K., Bos, L., Brett, P., Gibbons, M.C. (eds) Handbook of Digital Homecare. Series in Biomedical Engineering. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01387-4_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-01387-4_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01386-7
Online ISBN: 978-3-642-01387-4
eBook Packages: EngineeringEngineering (R0)